Gessler M - Search Results

1

TRIM28 haploinsufficiency predisposes to Wilms tumor.

Diets IJ, Hoyer J, Ekici AB, Popp B, Hoogerbrugge N, van Reijmersdal SV, Bhaskaran R, Hadjihannas M, Vasileiou G, Thiel CT, Seven D, Uebe S, Ilencikova D, Waanders E, Mavinkurve-Groothuis AMC, Roeleveld N, de Krijger RR, Wegert J, Graf N, Vokuhl C, Agaimy A, Gessler M, Reis A, Kuiper RP, Jongmans MCJ, Metzler M. Diets IJ, et al. Among authors: gessler m. Int J Cancer. 2019 Aug 15;145(4):941-951. doi: 10.1002/ijc.32167. Epub 2019 Feb 14. Int J Cancer. 2019. PMID: 30694527 Free article.

2

Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters.

Klamt B, Schulze M, Thäte C, Mares J, Goetz P, Kodet R, Scheulen W, Weirich A, Graf N, Gessler M. Klamt B, et al. Among authors: gessler m. Genes Chromosomes Cancer. 1998 Aug;22(4):287-94. doi: 10.1002/(sici)1098-2264(199808)22:4<287::aid-gcc4>3.0.co;2-r. Genes Chromosomes Cancer. 1998. PMID: 9669666

3

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

4

All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.

Zirn B, Samans B, Spangenberg C, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Oncogene. 2005 Aug 4;24(33):5246-51. doi: 10.1038/sj.onc.1208725. Oncogene. 2005. PMID: 15897880

5

Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.

Zirn B, Hartmann O, Samans B, Krause M, Wittmann S, Mertens F, Graf N, Eilers M, Gessler M. Zirn B, et al. Among authors: gessler m. Int J Cancer. 2006 Apr 15;118(8):1954-62. doi: 10.1002/ijc.21564. Int J Cancer. 2006. PMID: 16287080 Free article.

6

Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array.

Benetkiewicz M, Díaz de Ståhl T, Gördör A, Pfeifer S, Wittmann S, Gessler M, Dumanski JP. Benetkiewicz M, et al. Among authors: gessler m. Int J Cancer. 2006 Aug 1;119(3):571-8. doi: 10.1002/ijc.21868. Int J Cancer. 2006. PMID: 16496407 Free article.

7

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. Zirn B, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319. Genes Chromosomes Cancer. 2006. PMID: 16575872

8

Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.

Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2007 Feb;46(2):163-70. doi: 10.1002/gcc.20397. Genes Chromosomes Cancer. 2007. PMID: 17099873

9

New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors.

Wittmann S, Wunder C, Zirn B, Furtwängler R, Wegert J, Graf N, Gessler M. Wittmann S, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2008 May;47(5):386-95. doi: 10.1002/gcc.20544. Genes Chromosomes Cancer. 2008. PMID: 18260125

10

WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.

Wegert J, Wittmann S, Leuschner I, Geissinger E, Graf N, Gessler M. Wegert J, et al. Among authors: gessler m. Genes Chromosomes Cancer. 2009 Dec;48(12):1102-11. doi: 10.1002/gcc.20712. Genes Chromosomes Cancer. 2009. PMID: 19760609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page